Vaidya Sane Ayurved Laboratories Ltd

About the Company:

Vaidya Sane Ayurved Laboratories Ltd (madhavbaug) is a unique medical service institution that strives to treat chronic ailments like cardiac disease, diabetes, hypertension and obesity with the distinctive outlook of amalgamating technology with traditional healing of Ayurveda.

Company’s approach to treatment using non-invasive, multidisciplinary and innovative therapies has helped establish company as a dependable option for treating the
chronic ailments.

Company is a health care provider primarily in the India’s chronic care ecosystem and provides healthcare services through Madhavbaug clinics.

As on November 30, 2021, company operates 274 clinics across Maharashtra, Madhya Pradesh, Gujarat, Uttar Pradesh, Goa, Karnataka, Delhi and Chhattisgarh. Out of these 52 are company owned and 222 are franchise clinics.

Company also operates two cardiac prevention and rehabilitation hospitals in Khopoli and Nagpur respectively.

Currently company’s network includes 274 Clinics and 2 Fully equipped Hospital.




MOU with Vaidya Sane’s Ayurvedic Education And Agricultural Research Trust.

Vaidya Sane’s Ayurvedic Education And Agricultural Research Trust is providing non invasive medical services through the Khopoli Hospital.

Company has entered into MOU dated April 1, 2019 with Vaidya Sane’s Ayurvedic Education And Agricultural Research Trust for the entire management, medical services and treatments being carried out at Khopoli Hospital.

In consideration the trust shall pay Company 80% of the total fees/ amount received by it under this arrangement on monthly basis after providing for all reasonable expenses and applicable taxes.



Plans to Expand Clinic Network.

As part of company’s future growth strategy, company proposes to expand and strengthen the existing clinic network.

Company will position new clinics in strategic locations in Maharashtra and expand Clinic Network in Madhya Pradesh, Uttar Pradesh and Gujarat.

Company further intends to Open Franchisee OPD clinics in Tier II & III cities to increase reach. Company also has plans to further expand Khopoli and Nagpur Hospitals.



Management Team:

  1. Dr. Rohit Madhav Sane (Designation: Managing Director & CEO)
  2. Dr. Vidyut B. Ghag (Designation: Whole Time Director)



Financials of the Company:

(in Crores) FY 19 FY 20 FY 21 30th Sept 21
Revenue 62.56 75.29 52.27 31.56
Net Profit 0.49 (-0.55) 1.54 1.35




Objectives of the Issue:

Fresh Issue: (Rs.20.2 cr )

  • Funding Branding and Advertising expenses.
    General Corporate Purposes.




Peer Group Comparison:

  • Company does not have any listed peers which are comparable in terms of business.



IPO Details:

Details Info
Issue Opens on 10th February 2022
Issue Closes on:. 15th February 2022
Issue Price Rs.73
Face Value Rs.10
Minimum Lot 1600
Minimum Investment Rs.1,16,800
Issue Constitutes 26.36%
Issue Size Rs.20.2 cr
Market Cap Rs.76.7 cr
Listing at NSE SME
Equity Shares Offered (Fresh) 27,71,200
Equity Shares Prior to the Issue 77,42,250
Equity Shares after the issue 1,05,13,450

Also Read : List of Upcoming IPO’s in India.
Also Read : List of Upcoming SME IPO’s in India.



Important Dates:

Finalization of Basis of Allotment on or Before 18th February 2022
Initiation of Refunds on or Before 21st February 2022
Credit of Equity Shares: on or Before 22nd February 2022
Listing Date: on or Before 23rd February 2022



IPO Valuation Parameters:

Earnings Per Share (EPS) Price To Earnings ratio (PE) Return on Net Worth (RoNW) Net Asset Value (NAV)
2.22 32.88 15.84% 15.95



Check IPO Allotment Status:


BSE IPO Website:



Company Contact Info:
Vaidya Sane Ayurved Laboratories Ltd
Fl. 5, 1047, Shriram Bhawan,
Shukrawar Peth, Pune – 411002,
Maharashtra, India;
Tel: +91 7738070019;


IPO Registrar Info:
1st Floor, Bharat Tin Works Building,
Opp. Vasant Oasis, Makwana Road, Marol, Andheri East,
Mumbai – 400 059, Maharashtra, India
Tel. No.: +91 22 6263 8200



Lead Manager to the Issue:
1-2 Bhupen Chambers, Dalal Street, Fountain,
Mumbai – 400 001, Maharashtra, India.
Tel No.: +91 22 4050 9999
Fax No: +91 22 4050 9900
Email: /
Investor Grievance Email: